Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BRINSUPRI safely and effectively. See full prescribing information for BRINSUPRI. BRINSUPRI® (brensocatib) tablets, for oral useInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.
- generic_name
- brensocatib
- product_names
- Brensocatib
- ndc
- 71558-002, 71558-001, 71558-002-30, 71558-001-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en